Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

SLGB vs CYRX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CYRX Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

CYRX Overall Winner 6-Pillar Tally: SLGB 2 – 4 CYRX Matrix Metrics: SLGB 3 – 7 CYRX

As of Nov 16, 2026, CryoPort, Inc. (CYRX) is the stronger overall head-to-head candidate over SLGB (SLGB) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). SLGB carries a Unified Composite Score of 47.2/100 (HOLD) at $0.18 (N/M Forward P/E, -2.3% operating margin), whereas CYRX carries 36.5/100 (SELL) at $19.64 (93.5x Forward P/E, -14.4% operating margin).

  • Composite vs. Pillar Nuance: While SLGB currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CYRX 36.5/100 SELL), CYRX captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-14.4% vs. -2.3% operating margin) and revenue trajectory (+13.5% vs. -22.1% YoY).
  • Technical & Structure Timing Caution: SLGB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.4); meanwhile CYRX trades in a Markup technical trend (BREAKOUT options phase, RSI 61.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SLGB vs CYRX
SLGB US Equity
SLGB
Institutional Equity
$0.18
+1.98% 1D
Market Cap $8.1M
TTM Revenue $629M
Forward P/E N/M
Beta / 30D Vol -0.05β · 207% Vol
Unified Composite Score
47.2 / 100 HOLD
Tech 55.0 Fund 53.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -31.0%), weak momentum, RSI 37
RSI-14: 37.4 · SMA20: $0.22 · SMA50: $0.27
CYRX NASDAQ Head-to-Head Winner
CryoPort, Inc. Common Stock
Pharmaceutical Preparations
$19.64
-1.26% 1D
Market Cap $1.0B
TTM Revenue $192M
Forward P/E 93.5x
Beta / 30D Vol 1.58β · 85% Vol
Unified Composite Score
36.5 / 100 SELL
Tech 50.0 Fund 40.0 Flow 64.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.3% over 20 days), RSI 62
RSI-14: 61.9 · SMA20: $18.43 · SMA50: $17.52

6-Pillar Scorecard Institutional Category Breakdown (SLGB 2 – 4 CYRX)

Columns: Metric · SLGB · CYRX
1. Valuation Multiples CYRX
Forward P/E N/M 93.5x
Trailing P/E N/M 93.5x
PEG Ratio N/M N/M
EV / Revenue N/M 5.0x
2. Growth & Scale CYRX
Revenue Growth (YoY) -22.1% +13.5%
Earnings Growth (YoY) +356.9% +0.0%
TTM Revenue (USD) $629M $192M
Market Cap $8.1M $1.0B
3. Profitability & Quality SLGB
Gross Margin 4.7% 46.9%
Operating Margin -2.3% -14.4%
Net Profit Margin -2.9% -21.5%
Return on Equity (ROE) -14.7% -7.4%
4. Balance Sheet & Cash Flow SLGB
Cash Generation (TTM) -$12M EBITDA -$20M
Cash Flow Margin -2.0% EBITDA Mgn -10.3%
Net Cash / Leverage $0.47 Book/Sh · -14.7% ROE $48M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CYRX
Options Structure Phase UNCLASSIFIED BREAKOUT
Current IV / %ile N/A (N/A) 44.3% (6th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown ACCUMULATION · Markup
6. R&D & Supply-Chain Moat CYRX
OpEx & R&D Intensity 7.0% of Rev ($44M) 61.3% of Rev ($118M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Integrated Freight & Logistics Operator Integrated Freight & Logistics Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SLGB (3) vs CYRX (7)
Institutional Metric SLGB CYRX Criterion Row Edge
Market Capitalization
Scale
$8.1M $1.0B Larger Scale CYRX
Trailing P/E Ratio
Valuation
N/M 93.5x Lower Multiple CYRX
Forward P/E Ratio
Valuation
N/M 93.5x Lower Multiple CYRX
Revenue Growth (YoY)
Growth
-22.1% +13.5% Higher Growth CYRX
Operating Margin (TTM)
Profitability
-2.3% -14.4% Higher Margin SLGB
Net Profit Margin
Profitability
-2.9% -21.5% Higher Margin SLGB
Return on Equity (ROE)
Capital Efficiency
-14.7% -7.4% Higher ROE CYRX
52-Week Range Position
Momentum
1% ($0–$4) 85% ($8–$22) Stronger Trend CYRX
Beta / 30D Volatility
Risk Regime
-0.05β · 207% Vol 1.58β · 85% Vol Lower Realized Risk CYRX
Unified Institutional Score
Composite Signal
47.2 / 100 (HOLD) 36.5 / 100 (SELL) Higher Composite SLGB
Trailing 12M Revenue (USD)
Operating Scale
$629M $192M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
4.7% 46.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 5.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$12M EBITDA ($0.47 Book/Sh · -14.7% ROE) -$20M ($48M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CYRX +32.16 pp
SLGB: -15.53% · CYRX: +16.63%
3M Horizon CYRX +95.76 pp
SLGB: -65.61% · CYRX: +30.15%
6M Horizon CYRX +111.98 pp
SLGB: -64.42% · CYRX: +47.56%
1Y Horizon CYRX +214.95 pp
SLGB: -90.75% · CYRX: +124.2%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SLGB vs CYRX. Trailing 12-month operating profitability (SLGB -2.3% vs CYRX -14.4%) and valuation multiples (SLGB N/M vs CYRX 93.5x Forward P/E) are benchmarked directly in Pillar 4 below.

SLGB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$629M
Gross Margin4.7%
Op. Margin-2.3%
ROE / Fwd P/E-14.7% · N/M
CYRX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$192M
Gross Margin46.9%
Op. Margin-14.4%
ROE / Fwd P/E-7.4% · 93.5x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SLGB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SLGB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CYRX BREAKOUT
115d in phase · OBV ACCUMULATION
Current IV 44.3%
IV Percentile 6th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact CYRX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SLGB Moat Profile Cyclical / Execution-Driven Positioning
Integrated Freight & Logistics Operator
Competes within the Integrated Freight & Logistics value chain with $8.1M market capitalization and -2.3% operating margin.
OpEx & R&D Reinvestment 7.0% of Rev ($44M)
90D Engineering Disclosures 0 Published
CYRX Moat Profile Cyclical / Execution-Driven Positioning
Integrated Freight & Logistics Operator
Competes within the Integrated Freight & Logistics value chain with $1.0B market capitalization and -14.4% operating margin.
OpEx & R&D Reinvestment 61.3% of Rev ($118M)
90D Engineering Disclosures 0 Published

Investor FAQ SLGB vs CYRX Key Questions & Quantitative Answers

As of Nov 16, 2026, CryoPort, Inc. (CYRX) is the stronger overall head-to-head candidate over SLGB (SLGB) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). SLGB carries a Unified Composite Score of 47.2/100 (HOLD) at $0.18 (N/M Forward P/E, -2.3% operating margin), whereas CYRX carries 36.5/100 (SELL) at $19.64 (93.5x Forward P/E, -14.4% operating margin). Composite vs. Pillar Nuance: While SLGB currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CYRX 36.5/100 SELL), CYRX captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-14.4% vs. -2.3% operating margin) and revenue trajectory (+13.5% vs. -22.1% YoY). Technical & Structure Timing Caution: SLGB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.4); meanwhile CYRX trades in a Markup technical trend (BREAKOUT options phase, RSI 61.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CYRX leads the Growth & Scale pillar: SLGB posts -22.1% YoY revenue growth and +356.9% YoY earnings growth on $629M TTM revenue (4.7% gross margin, -2.3% operating margin), compared with CYRX at +13.5% YoY revenue growth and +0.0% YoY earnings growth on $192M TTM revenue (46.9% gross margin, -14.4% operating margin). On trailing 12-month operating scale, SLGB generates $629M in USD-normalized revenue versus $192M for CYRX. In operating R&D and SG&A reinvestment, SLGB deploys 7.0% of Rev ($44M) (0 90-day corporate R&D disclosures) versus 61.3% of Rev ($118M) (0 disclosures) for CYRX.

CYRX screens cheaper on headline valuation multiples. SLGB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-2.0% EBITDA margin), whereas CYRX trades at 93.5x Forward P/E, 93.5x Trailing P/E, N/M PEG, and 5.0x EV/Revenue (-10.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SLGB (-14.7% ROE) versus CYRX (-7.4% ROE) capital efficiency.

In options market volatility and institutional positioning, SLGB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.05β · 207% Vol realized risk). By comparison, CYRX carries 44.3% implied volatility (6th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (1.58β · 85% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.